Stronger Together: Advancing Breast AI Through Strategic Partnerships

Transpara® Breast AI integrates seamlessly across the technologies radiologists rely on every day. Through collaborations with leading PACS providers, AI platforms, and imaging technology partners, ScreenPoint Medical helps bring AI into clinical workflows without disruption. 

Every breast imaging environment is different.

That’s why Transpara® Breast AI is designed to integrate seamlessly across PACS systems, AI platforms, and imaging solutions.

Whether radiologists are working within their existing reading environment or leveraging enterprise AI platforms, Transpara® supports efficient, AI-enhanced breast cancer screening without disrupting established workflows.

Native Integration

Transpara® Breast AI is built to integrate directly within the technologies radiologists already use. Through collaborations with leading PACS providers, AI platforms, and imaging technologies, Transpara® delivers AI insights within existing clinical workflows - allowing radiologists to benefit from advanced decision support without disrupting their reading environment.

Designed for flexibility, Transpara® supports integration across diverse imaging infrastructures and enterprise healthcare systems.

Built for Global Clinical Deployment

Transpara® Breast AI is FDA-cleared and CE-marked under MDR and is deployed across healthcare systems worldwide in over 30 countries. Designed for large-scale screening programs and enterprise imaging environments, Transpara® supports the technical, regulatory, and operational requirements of modern breast imaging networks.

Evidence Backed Impact

Transpara® Breast AI is backed by one of the largest bodies of clinical evidence in breast imaging AI, including 55+ peer-reviewed studies, 11 million mammograms analyzed, and three randomized controlled trials, including the landmark MASAI study, the largest RCT in medical AI history. Read more about our evidence here.

Our Trusted Partners


What our Partners Say

"ScreenPoint’s Transpara Breast AI is one of the most clinically validated breast AI solutions in the world, and its availability on Ferrum’s Model Hub reflects what health systems are demanding right now: proven performance, real-world scale, and trust."
Screenshot 2026-03-26 123417
Peter Eason
COO, Ferrum Health
“By integrating Transpara solutions with Precision Imaging Network , ScreenPoint Medical offers providers an efficient pathway to access breast imaging decision support while taking advantage of the security and scalability of Microsoft’s for Healthcare’s platform and presence.”
Screenshot 2026-03-26 123709
Vikram Chhabra
Vice President, Medical Imaging AI Solutions at Microsoft
“Transpara is a clinically validated solution that enhances the interpretation of both 2D and 3D mammography exams. Integrated solutions that deliver more effective breast cancer detection create tangible value for radiologists and patients—something that’s at the forefront of what we support every day.”
Screenshot 2026-03-26 124025
Emily Crane
CEO & President,Ikonopedia
"Fujifilm is thrilled to form and expand partnerships with leading companies that share the same commitment to improve patient lives through advances in breast imaging technology. By collaborating with ScreenPoint Medical, we are offering our customers the latest, intelligent clinical decision-support tools they need to improve mammography quality and identify potential breast cancers faster and earlier than before."
Screenshot 2026-03-31 084724
Christine Murray
Women's Health Marketing Director, FujiFilm Healthcare Americas
“Taking into consideration IT security, speed, and ease of deployment, we found ScreenPoint Medical to be the ideal partner for Aidoc in the women’s health space...We look forward to including ScreenPoint products within our robust AI platform, providing value for key clinical use cases as part of a unified and seamless cross-specialty AI experience.”
Screenshot 2026-04-01 194525
Tom Valent
VP of Business Development, Aidoc